{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:07Z","timestamp":1786119367333,"version":"build-2736575974"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1097\/mbc.0b013e32832fb1b9","type":"journal-article","created":{"date-parts":[[2009,10,29]],"date-time":"2009-10-29T03:17:35Z","timestamp":1256786255000},"page":"719-721","source":"Crossref","is-referenced-by-count":6,"title":["Acquired factor VIII inhibitors: case reports of paclitaxel and penicillin \u2013 induced entities"],"prefix":"10.1097","volume":"20","author":[{"given":"Hazem","family":"El-Osta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavan","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy M","family":"Deutsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210203","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0002-9343(98)00289-7","article-title":"Acquired hemophilia due to factor VIII inhibitors in 34 patients","volume":"105","author":"Bossi","year":"1998","journal-title":"Am J Med"},{"key":"R2-17-20210203","first-page":"437","article-title":"Acquired factor VIII inhibitors: pathophysiology and treatment.","volume":"432-","author":"Ma","year":"2006","journal-title":"Hematology"},{"key":"R3-17-20210203","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2141.1995.tb03294.x","article-title":"Acquired haemophilia and its management","volume":"89","author":"Morrison","year":"1995","journal-title":"Br J Haematol"},{"key":"R4-17-20210203","first-page":"55","article-title":"Drug-induced antifactor VIII antibodies: a systematic review","volume":"13","author":"Franchini","year":"2007","journal-title":"Med Sci Monit"},{"key":"R5-17-20210203","first-page":"612","article-title":"Proceedings: A more uniform measurement of factor VIII inhibitors","volume":"34","author":"Kasper","year":"1975","journal-title":"Thromb Diath Haemorrh"},{"key":"R6-17-20210203","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1046\/j.1365-2141.2002.03835_5.x","article-title":"Treatment of refractory autoimmune (acquired) haemophilia with anti-CD20 (rituximab)","volume":"119","author":"Kain","year":"2002","journal-title":"Br J Haematol"},{"key":"R7-17-20210203","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1182\/blood-2002-03-0765","article-title":"Rituximab in the treatment of acquired factor VIII inhibitors","volume":"100","author":"Wiestner","year":"2002","journal-title":"Blood"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001721-200912000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:05:08Z","timestamp":1786039508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-200912000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":7,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e32832fb1b9","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}